Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
Wagner KD, Asarnow JR, Vitiello B, Clarke G, Keller M, Emslie GJ, Ryan N, Porta G, Iyengar S, Ritz L, Zelanzny J, Onorato M, Brent D. Wagner KD, et al. Among authors: ritz l. J Child Adolesc Psychopharmacol. 2012 Feb;22(1):5-10. doi: 10.1089/cap.2011.0045. Epub 2012 Jan 17. J Child Adolesc Psychopharmacol. 2012. PMID: 22251022 Free PMC article. Clinical Trial.
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J. Brent D, et al. Among authors: ritz l. JAMA. 2008 Feb 27;299(8):901-913. doi: 10.1001/jama.299.8.901. JAMA. 2008. PMID: 18314433 Free PMC article. Clinical Trial.
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Asarnow JR, Emslie G, Clarke G, Wagner KD, Spirito A, Vitiello B, Iyengar S, Shamseddeen W, Ritz L, Birmaher B, Ryan N, Kennard B, Mayes T, DeBar L, McCracken J, Strober M, Suddath R, Leonard H, Porta G, Keller M, Brent D. Asarnow JR, et al. Among authors: ritz l. J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):330-339. doi: 10.1097/chi.0b013e3181977476. J Am Acad Child Adolesc Psychiatry. 2009. PMID: 19182688 Free PMC article. Clinical Trial.
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB. Brent DA, et al. Among authors: ritz l. Am J Psychiatry. 2009 Apr;166(4):418-26. doi: 10.1176/appi.ajp.2008.08070976. Epub 2009 Feb 17. Am J Psychiatry. 2009. PMID: 19223438 Free PMC article. Clinical Trial.
Cognitive effects of risperidone in children with autism and irritable behavior.
Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, Posey DJ. Aman MG, et al. Among authors: ritz l. J Child Adolesc Psychopharmacol. 2008 Jun;18(3):227-36. doi: 10.1089/cap.2007.0133. J Child Adolesc Psychopharmacol. 2008. PMID: 18582177 Free PMC article. Clinical Trial.
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group. Abikoff H, et al. Among authors: ritz l. J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27. doi: 10.1097/01.chi.0000155320.52322.37. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 15843763 Clinical Trial.
Acute and long-term safety and tolerability of risperidone in children with autism.
Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Aman MG, et al. Among authors: ritz l. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84. doi: 10.1089/cap.2005.15.869. J Child Adolesc Psychopharmacol. 2005. PMID: 16379507 Clinical Trial.
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.
McCLELLAN J, Sikich L, Findling RL, Frazier JA, Vitiello B, Hlastala SA, Williams E, Ambler D, Hunt-Harrison T, Maloney AE, Ritz L, Anderson R, Hamer RM, Lieberman JA. McCLELLAN J, et al. Among authors: ritz l. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):969-978. doi: 10.1097/CHI.0b013e3180691779. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17667476 Clinical Trial.
111 results